[Association of leptin with anthropometric indexes, dyslipidemia and carbohydrate metabolism in Kazakh adults].

Leptin plays an important role in eating behavior, the central action of this hormone is the regulation of appetite and energy expenditure. Anthroponutritiology as a new scientific direction uses the methods of medical anthropology and nutritional science. The study of the relationship between the regulation of energy metabolism, taking into account constitutional features, and anthropometric parameters provides relevance in this direction. The purpose of the research was to study of the relationship between blood serum leptin level and body mass index (BMI) and indicators of lipid profile, carbohydrate metabolism in adult Kazakh population. Material and methods. The sample of the prospective study was 109 persons aged 18-60 years, who were divided depending on BMI into 5 groups, randomized by age and sex. We measured anthropometric parameters and biochemical parameters: serum leptin concentration, fasting blood glucose, insulin, glycated hemoglobin, HOMA-IR, lipid profile (concentration of cholesterol, low and high density lipoproteins, triglycerides, atherogenic index). Results. In the sample studied, we found that in Kazakh adults, serum leptin level correlated with BMI (ρ=0.57; p<0.01). The highest values were observed at a BMI greater than 40 kg/m2, amounting to 54.9 [33.3; 78.4] vs 10.0 [4.8; 23.1] ng/ml in overweight individuals (p=<0.005). In women, leptin levels were almost 2-fold higher than in men (24.2 vs 12.9 ng/ml, p=<0.001). No significant correlations of leptin level with age and lipid profile have been found. There was a positive association of leptin with insulin (ρ=0.28, p<0.01) and the HOMA-IR (ρ=0.21, p<0.05). Conclusion. The study showed that leptin blood level is associated with constitutional features, the highest values were found in persons with a high degree of obesity. Perhaps this result is associated with leptin resistance. Diagnostic criteria of leptin resistance are currently poorly studied. Taking into consideration clinical and specific actions of leptin there is a place for its further study as a potential biomarker of obesity.

[PECULIARITIES OF PREGNANCY COURSE AND DELIVERY OUTCOMES IN WOMEN WITH VARIOUS FORMS OF ARTERIAL HYPERTENSION].

The aim of the study was to compare blood pressure levels at specific periods of pregnancy, antihypertensive treatment regimens, pregnancy and childbirth outcomes in women with CAH and GAG to develop a differentiated approach to the management of pregnant women with hypertension. A prospective cohort study was conducted on the dynamic observation of 110 pregnant women with hypertension on the basis of perinatal centers №1 and №3 of Nur-Sultan (Kazakhstan) in 2018-2019. The main method for monitoring blood pressure was an office measurement, which was carried out in a perinatal center with an Omron HEM-FL31-E apparatus in compliance with the ESC 2018 recommendations. The comparative analysis included indicators of average office blood pressure during gestation: 14-16, 20-22, 28-30, 34-36 weeks of pregnancy, as well as 2 weeks, 2 and 3 months after delivery. The results of the study show that despite constant monitoring of blood pressure and antihypertensive therapy, blood pressure in the main group is statistically significantly higher than in the control group. Against the background of higher levels of SBP and DBP in pregnant women with CAH, with the regular use of antihypertensive therapy, more unfavorable outcomes of pregnancy and childbirth were observed compared with the group of pregnant women with GAG. Despite the fact that the frequency of complications such as PE, prenatal discharge of amniotic fluid, and atonic bleeding in pregnant women with GAG was more common, outcomes of labor are more unfavorable for pregnant women with CAH. Violation of the BMD (IA, IB, II degrees), distress, the birth of a small fetus were more common in the group of pregnant women with CAH. While the frequency of pregnancy complications is relatively the same in both groups, the outcome of labor is more favorable in the group of pregnant women with GAG. Perhaps this is due to a violation of the BMD in the group of pregnant women with CAH, which subsequently affects a less favorable outcome of the birth.

The frequency of familial hypercholesterolemia amongst patients in the outpatient clinic of the tertiary specialized cardiology center in Kyrgyzstan.

BACKGROUND: Familial hypercholesterolemia (FH) is frequently underdiagnosed. Prevalence of the FH in Kyrgyzstan is unknown. AIM: to investigate the prevalence of FH amongst patients in the outpatient settings of the tertiary cardiologic center in Kyrgyzstan. METHODS: Retrospective observational study was conducted using the database of the laboratory of biochemistry and electronic database of outpatient department of the National Center of Cardiology and internal diseases. Patient with the level of total cholesterol (TC) ≥7,5 mmol/l and/or low density lipoprotein cholesterol (LDL-C) ≥ 4,9 mmol/l without signs of secondary hyperlipidemia were included in the analysis. FH was defined using Dutch Lipid Clinic Network criteria. RESULTS: according to the laboratory database levels of TC and LDL-C was conducted in 8281patiens and 525 of them had a high lipid levels. After exclusion of patients with secondary hyperlipidemia, high level of triglycerides and pregnant women - 91 patients were included in the analysis. Among them the definite FH was revealed in 2 (2,2%) patients, probable FH - in 6 (6,6%), and possible in 76 (83,5%), and in 7,7% there were no signs of FH. CONCLUSION: Frequency of potential FH (definite and probable) in our analysis was low. To understand the real prevalence of FH in a Kyrgyz population epidemiological study is needed.

[THE DIFFERENCES OF CHANGES IN BODY WEIGHT ON THE HYPERTENSION IN ADOLESCENTS 12-13 YEARS].

The aim of the research was to study the differences of overweight, obesity to the level of AH among 12-13 years old. We carried out a cross-sectional study of 1493 adolescents aged 12-13 years in Semey. The risk factor of diseases of the circulatory system was studied, such as obesity and its correlation with the level of arterial pressure. The population with normal blood pressure (BP) was 87.4% (n=1305), persons with arterial hypertension (AH) (1 and 2 degrees) 12.6% (n=188). There were no statistically significant differences in prevalence of AH by ethnicity (Pearson's χ² criterion = 0.18, df=1, p=0.671). By weight, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), statistically significant differences were detected (p <0.001). According to the data of the study, the following data were revealed in the structure of individuals with normal BP according to the value of BMI: underweight in 29.5% (n=385), normal weight in 65.1% (n = 850), overweight in 4.7% (n=61), obesity in 0.7% (n=9). In the structure of persons with arterial hypertension, the BMI value was: underweight 12.3% (n=23), normal weight 66.7% (n=126), overweight 19.4% (n=36), obesity 1.6% (n=3). A significant prevalence of hypertension in the population of adolescents aged 12-13 years was found, roughly to 12.6%. In the groups of adolescents with normal BP and AH, statistically significant differences in the ratio of the body weight categories of adolescents determined by BMI were revealed, to a greater extent this was related to overweight.

[Risk of type 2 diabetes mellitus in the Kyrgyz population in the presence of ADIPOQ (G276T), KCNJ11 (Glu23Lys), TCF7L2 (IVS3C>T) gene polymorphisms]. / Risk razvitiia sakharnogo diabeta 2-go tipa v kyrgyzskoi populiatsii pri nalichii polimorfizmov G276T gena ADIPOQ, Glu23Lys gena KCNJ11 i IVS3C>T gena TCF7L2.

AIM: To analyze the association of genotype combinations of the polymorphic markers G276T in the ADIPOQ gene, Glu23Lys in the KCNJ11 gene, and IVS3C>T in the TCF7L2 gene with the development of type 2 diabetes mellitus (T2DM) in the Kyrgyz population. SUBJECTS AND METHODS: The investigation enrolled 23 Kyrgyz people, of whom there were 114 patients with T2DM and 109 without T2DM (a control group). T2DM was diagnosed in accordance with the WHO criteria (1999). The genotypes of ADIPOQ (G276T), KCNJ11 (Glu23Lys), and TCF7L2 (IVS3C>T) gene polymorphisms were identified using the restriction fragment length polymorphism analysis. RESULTS: When typing at the polymorphic loci G276T in the ADIPOQ gene, Glu23Lys in the KCNJ11 gene, and IVS3C>T in the TCF7L2 gene, the development of T2DM in the Kyrgyz population was associated with the T allele (odds ratio (OR), 1.68; p=0.025), the heterozygous G276T genotype (OR 1,8; p=0.036) in the ADIPOQ gene; the 23Lys allele (OR, 1.62; p=0.019) in the KCNJ11 gene; a two-locus genotype combination in the genes ADIPOQ/KCNJ11: G276T/Glu23Lys (OR, 4.88; p=0.0013), G276G/Lys23Lys (OR, 4.65; p=0.019), G276T/Glu23Glu (OR, 3.10; p=0.022), a two-locus genotype combination in the genes ADIPOQ/TCF7L2: G276T/СС (OR, 1.97; p=0.04); two-locus genotype combinations in the genes KCNJ11/TCF7L2: Lys23Lys/CC (ОR, 2.65; p=0.042), Glu23Lys/CT (OR, 3.88; p=0.027); and a three-locus genotype combination in the genes ADIPOQ/KCNJ11/TCF7L2: G276T/Glu23Lys/CT (OR, 14.48; p=0.02). CONCLUSION: The development of T2DM in the Kyrgyz population is genetically determined by ADIPOQ (G276T) gene, KCNJ11 (Glu23Lys), and TCF7L (IVS3C>T) gene polymorphisms with the predisposing value of the T allele of the heterozygous G276T genotype in the ADIPOQ gene; the 23Lys allele in the KCNJ1 gene; as well as by genotype combinations in the genes ADIPOQ/KCNJ11 (G276T/Glu23Lys, G276G/Lys23Lys, G276T/Glu23Glu); ADIPOQ/TCF7L2 (G276T/SS); KCNJ11/TCF7L2 (Lys23Lys/CC, Glu23Lys/CT); ADIPOQ/KCNJ11/TCF7L2 (G276T/Glu23Lys /CT). The IVS3C>T locus in the TCF7L2 gene is not independently statistically significantly associated with the development of T2DM; however, its predisposing effect has been identified in its combination with the variant genotypes of the polymorphic loci G276T in the ADIPOQ gene and Glu23Lys in the KCNJ11 gene.

[Association of the polymorphic marker Glu23Lys in the KCNJ11 gene with hypertension in Kyrgyz patients]. / Assotsiatsiia polimorfnogo markera Glu23Lys gena KCNJ11 s razvitiem arterial'noi gipertonii u patsientov kirgizskoi natsional'nosti.

AIM: To study the association of the polymorphic marker Glu23Lys in the KCNJ11 with the development of hypertension in Kyrgyz patients. SUBJECTS AND METHODS: This case-control study enrolled 214 unrelated ethnic Kyrgyzes, in which a study group included 152 hypertensive patients (82 men and 70 women) and a control group consisted of 109 apparently healthy individuals (61 men and 48 women). The examinees' mean age was 55.2±10.1 years. Hypertension was verified when blood pressure (BP) was above 140/90 mm Hg. Polymerase chain reaction-restriction fragment length polymorphism analysis was used to identify the polymorphic marker Glu23Lys in the KCNJ11 gene. RESULTS: In the hypertension and control groups, the prevalence of 3 genotypes (Glu23Glu, Glu23Lys, and Lys23Lys) of the Glu23Lys polymorphism in the KCNJ11 gene differed significantly (χ2=8.04; p=0.018). The Lys23Lys and Glu23Lys genotypes were statistically more frequently recorded in the hypertension group and the homozygous Glu23Glu genotype was, on the contrary, more common in the control group than in the study one. In the hypertension group, the 23Lys allele frequency was statistically significantly higher than that in the control one (χ2=7.36; p=0.0067). The carriage of the 23Lys allele increased the risk of hypertension by 1.68 times (odds ratio (OR), 1.68; 95% confidence interval (CI), 1.17-2.41), that of the Glu23 allele had, on the contrary, a protective effect (OR, 0.60; 95% CI, 0.41-0.86). CONCLUSION: The polymorphic marker Glu23Lys in the KCNJ11 gene is associated with hypertension in the Kyrgyzes. The 23Lys allele is a marker for the higher risk of hypertension.

[An Association Between T455C Polymorphism of Apolipoprotein C-III Gene, Insulin Resistance and Metabolic Syndrome Components].

AIM: to study an association between T455C apolipoprotein C-III (apo C-III) gene polymorphism, insulin resistance (IR), metabolic syndrome (MS) and its components in a Kyrgyz ethnic group. MATERIAL AND METHODS: 259 persons: 162 patients with MS and 97 sex and age matched controls without MS, diabetes mellitus and cardiovascular diseases were included in the study. Clinical examination with arterial blood pressure, anthropometric data measurement and laboratory tests for blood glucose and lipid parameters were performed in all included persons. In 140 patients test for immunoreactive serum insulin was done. DNA was extracted from blood cells and T455C polymorphism of apo C-III gene was determined by PCR method. RESULTS: In examined persons the most frequent was TC genotype as in group with MS as in controls. The difference on genotype's frequency between group was close to significant level (χ2 =5.48; p = 0.06) and odd ratio (OR) for MS between CC and TT carriers was 2.57 (95% CI 1.15-5.72); p = 0.019). Frequency of 455C allele in control group was--0.44 and in group with MS--0.54 (χ2 = 4.55; p = 0.036). In carriers of CC genotype there was noted that the frequency of IR (61.8% vs 23.1% vs 36.3%; p < 0.005), insulin level (11.9 [7.04-16.3] vs 5.73 [3.34-10.3] vs 7.54 [4.59-12.2] µIU/ml; p < 0.01) and HOMA index (3.14 [1.66-4.79] vs 1.46 [0.8-2.6] vs 2.05 [1.12-3.6]; p < 0.01) were significantly higher compared with TT and TC genotypes groups respectively. OR for IR between CC and TT carriers was 5.39 (95% CI 1.7-16.9; p = 0.0028). There also was an association between CC genotype and other MS components such as abdominal obesity (χ2--6.24; p--0.044, OR (95% CI--2.21 [1.03-4.82]) and high level of blood triglycerides (χ2--7.57; p--0.022, OR (95% CI) 2.5 [1.14-5.5]). CONCLUSION: In examined Kyrgyz ethnic population the most frequent was heterozygous TC genotype of T455C polymorphism of apo C-III. An association of 455C allele and CC genotype with MS, IR, abdominal obesity and high level of triglycerides was revealed. Key words: apolipoprotein C-III; T455C gene polymorphism; metabolic syndrome, insulin resistance.

[Association of adiponectin gene G276T polymorphism with the development of metabolic syndrome in ethnic Kyrgyz patients]. / Assotsiatsiya polimorfnogo markera G276T gena adiponektina s razvitiem metabolicheskogo sindroma u patsientov kirgizskoi natsional'nosti.

AIM: To study the association of adiponectin gene G276Т (ADIPOQ) polymorphism with the development of metabolic syndrome (MS) in ethnic Kyrgyz patients. MATERIAL AND METHODS: A total of 171 patients with MS (a study group) and 117 patients without MS (a comparison group) were examined. MS was defined on the basis of the modified ATP III criteria. The genotypes of the G276T polymorphism in the adiponectin gene were determined by polymerase chain reaction-restriction fragment length polymorphism analysis. RESULTS: Dividing the MS and control groups by gender revealed statistically significant differences in the distribution of alleles and genotypes only among the women. There was a higher frequency of GT+TT genotypes (53% vs 34%; χ2=5.942; р=0.014) and T allele (30% vs 19%; χ2=4.489; р=0.0341) in the women with MS than in those without MS. Iin the ethnic Kyrgyz women, the T allele at the G276Т polymorphic locus in the ADIPOQ gene was associated with the development of MS (odds ratio (OR)=1.82; 95% confidence interval (CI) 1.04-3.19) and type 2 diabetes mellitus (T2DM) (OR=2.63; 95% CI, 1.05-6.56 ) with the high levels of leptin (p<0.05), glucose (p<0.05), triglycerides (OR=3.06; 95% CI, 1.05-8.93), low-density lipoprotein cholesterol (OR=2.80; 95% CI, 1,07-7.31) and with the lower level of high-density lipoprotein cholesterol (OR=2.9; 95% CI, 1.15-7.24). CONCLUSION: The risk for MS, T2DM, hyperglycemia, and dyslipidemia is related to the carriage of the T allele of the G276Т polymorphism in the ADIPOQ gene in ethnic Kyrgyz women.

[Association Between T455C Polymorphism of Apolipoprotein C-III Gene, Insulin Resistance and Metabolic Syndrome Components].

AIM: to study an association between T455C apolipoprotein C-III (apo C-III) gene polymorphism, insulin resistance (IR), metabolic syndrome (MS) and its components in a Kyrgyz ethnic group. MATERIAL AND METHODS: 259 persons: 162 patients with MS and 97 sex and age matched controls without MS, diabetes mellitus and cardiovascular diseases were included in the study. Clinical examination with arterial blood pressure, anthropometric data measurement and laboratory tests for blood glucose and lipid parameters were performed in all included persons. In 140 patients test for immunoreactive serum insulin was done. DNA was extracted from blood cells and T455C polymorphism.

[The association of leptin with dislipidemia in group of ethnic Kirghiz].

The article deals with results of evaluation of relationship between leptin and lipid indicators in group of ethnic Kirghiz. The sampling included 322 ethnic Kirghiz (145 males and 177 females) aged from 30 to 75 years. To all patients was applied general clinical examination, anthropometric examination (height, body mass, waist circumference, thighs circumference). The body mass index was calculated. The level of glucose (on an empty stomach), lipids spectrum and leptin of blood serum were measured. The average age of patients consisted 57.7 +/- 9.6 years and average level of leptin was 7.8 ng/ml. The patients were allocated to three groups depending of tertile of leptin (< 3; 3.0-5.51; > or = 5.52 ng/ml in males; 9.6; 9.6-16.6; > or = 16.7 ng/ml in females). In patients from upper tertile as compared with patients from lower tertiles are noted high values of triglycerides (p < 0.001), total cholesterol (p < 0.O01), in males and triglycerides (p = 0.02) in females. Leptin correlated with body mass index (in males: r = 0.68, p < 0.01; in females: r = 0.74, p < 0.001), concentration of triglycerides (in males: r = 0.301, p < 0.001; in females: r = 0.194, p < 0.001). Leptin correlated with total cholesterol in males (r = 0.214, p < 0.05) and with cholesterol of lipoproteins of high density in females (r = 0.156, p < 0.05). The level of leptin in group of ethnic Kirghiz is associated with dislipidemia, obesity, including abdominal obesity.

[Association of leptin with obesity and hypertension in an ethnic Kyrgyz group].

AIM: To study an association of the level of leptin, obesity, and hypertension in a group of ethnic Kyrgyz. SUBJECTS AND METHODS: Three hundred and twenty-two Kyrgyz people (145 men and 177 women) who were aged above 30 years and resided in the Kyrgyz Republic were examined. They underwent physical examination involving the collection of complaints and medical history data, objective examination, and anthropometric (height, weight, waist and hip circumference (WC and HC), body mass index (BMI)) and blood pressure (BP) measurements. The persons filled out the Finnish Diabetes Risk Assessment Form including data on vegetable consumption (daily or every other day) and exercise (more or less than 30 min per day). Fasting plasma glucose and serum leptin levels were determined. RESULTS: All the study participants were allocated to 4 groups according the quartile of leptin levels: < 2.2, 2.2-4.2, 4.3-6.34, and > 6.34 ng/ml for men and < 8.05, 8.05-13.4; 13.5-19.09, and > 19.09 ng/ml for women. The persons in the highest leptin quartile were found to have higher BMI, WC, systolic and diastolic BP (SBP and DBP), and blood glucose levels than those in the lowest quartile. Elevated leptin levels were associated with the higher risk of hypertension. Leptin levels correlated with BMI (r = 0.719; p < 0.001 for men and r = 0.74; p < 0.001 for women) and WC (r = 0.684; p < 0.001 for men; and r = 0.649; p < 0.001 for women). There was also a correlation of leptin levels with SBP (r = 0.355; p < 0.001 and r = 0.277; p < 0.001) and DBP (r = 0.426; p < 0.001 and r = 0.228; p < 0.01) in men and women, respectively. CONCLUSION: Leptin levels were associated with obesity and hypertension in the group of ethnic Kyrgyz people.

[An association of the 825 polymorphism of the g protein 3 subunit with obesity in Kyrgyz population].

GOAL: To study an association of G protein (GP) 3 subunit 825 polymorphism with obesity in native Kyrgyzes. MATERIAL AND METHODS: 210 persons: 89 patients (female - 35, male - 54) with obesity (body mass index [BMI] more or equal 30 kg/m2) and 121 apparently healthy controls (38 female, 83 male) with normal BMI. Arterial blood pressure, anthropometric measurement and laboratory tests for blood glucose and lipid parameters were performed in all examined persons. DNA was extracted from blood cells and GP3 subunit 825 polymorphism was determined by PCR method. RESULTS: groups with TT and CT genotypes were combined together because of the rare frequency of TT genotype. Prevalence of + genotypes in group with obesity (0.72) was significantly higher than in controls - 0.52 (odds ratio 2.55, 95% confidence interval [CI] 1.31-4.23; =0.004). Arterial hypertension (45 vs. 31.3%; =0,049) and obesity (51.2 vs. 30%; p<0.01) occurred more often in + genotypes carriers compared with CC homozygotes. A logistic regression model for obesity showed significant effect of 825T allele (relative risk [RR] 2.89, 95% CI 1.25-6.7; =0.013) and irregular intake of vegetables (RR 3.47, 95% CI 1.52-7.94; =0.003) as predictors of obesity development independent of age, sex and physical activity level. In the regression model for arterial hypertension the 825T allele lost its significance after adjustment for obesity. CONCLUSION: GP3 subunit 825 allele in native Kyrgyzes is associated with obesity.

[Association of C677T gene polymorphism of methylenetetrahydrofolate reductase with insulin resistance among Kirghizes].

AIM: To study an association of C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) and insulin resistance (IR) among ethical Kirghizes. METHODS: 132 Kirghiz patients with IR according to HOMA index (n=132) and sex and age matched patients without IR, diabetes mellitus (DM) type 2 or metabolic syndrome (MS) (n=132) were included into this study. Measurements of blood pressure (BP), body mass index, waist and hip circumference, fasting blood sugar, insulin, lipid parameters and C677T gene polymorphism of MTHFR were performed in all patients. RESULTS: Frequency of CT and TT genotypes was significantly higher in patients with IR than in controls (2 - 7.22, p - 0,027, OR - 1.68, 95% confidence interval 1.13-2.5, p=0.027). T677 allele was also associated with obesity, hypertriglyceridemia and low level of high density lipoprotein cholesterol (HDL-C). CONCLUSION: In Kirghizes carriage of T677 allele of MTHFR gene was associated with IR, abdominal obesity, hypertriglyceridemia and low HDL-C level.

[Association of the serum level of apolipoprotein E with coronary artery disease and carotid artery atherosclerosis in Kyrgyz men with dyslipidemia].

AIM: To study an association of the serum level of apolipoprotein E (apo-E) with risk factors for coronary heart disease (CHD), blood lipids and that with CHD and carotid artery (CA) atherosclerotic lesion in Kyrgyz men with dyslipidemia. SUBJECTS AND METHODS: One hundred and three Kyrgyz men, including 48 with CHD and 55 without this disease, were examined. A clinical examination was performed and blood lipid composition and serum glucose and apo-E levels were determined. The diagnosis of CHD was established in accordance with the conventional criteria. Whether atherosclerosis was present was determined by ultrasound duplex scanning. RESULTS: Low serum apo-E concentrations were associated with the presence of obesity, the higher blood levels of glucose and triglycerides. There was no correlation with other lipid metabolic parameters and the presence of CHD. A nonlinear relationship was noted between serum apo-E levels and CA atherosclerotic lesion, which was more frequently observed in patients with the apo-E level in the lower and upper quartiles. CONCLUSION: Low serum apo-E content is a poor factor and associated with obesity, hypertriglyceridemia, elevated serum glucose levels, and the development of CA atherosclerosis.

The phosphatidylinositol-protein nanocomplex as a new biosensor for ecological monitoring and clinical diagnostic.

Using chromatography on nanostructured carbon sorbent we had isolated an unusual nanocomplex from filling grains of wheat and maize, which consists of only phosphatidylinositol (PI) and one protein-glutamate dehydrogenase (GDh). It was very surprising that this nanocomplex shows activity of Nicotinamide adenine dinucleotide phosphate-GDh (NADP-GDh) without any treatment. Thus, the whole body of nanocomplex shows its activity without disturbing its integrity. This makes the nanocomplex very convenient for using it as a biosensor. The main feature of nanocomplex is its high sensitivity to ammonia ions. Linear response concentration for nanocomplex is from 0.5 microM to 10 microM ammonia ions. Due to these properties the nanocomplex may be very useful as nanobiosensor for ecological monitoring of pollution by sewer waters of natural reservoirs-lakes and rivers. Also this nanosensor can be applied for determination of ammonia ions, NADPH and 2-oxoglutarate in biological liquids for clinical diagnostic.

[The cyclicity of changes in the autonomic regulation of the hemodynamics and the effects of clofelin in women with hypertension]. / Tsiklichnost' izmenenii vegetativnoi reguliatsii gemodinamiki i éffekty klofelina u zhenshchin, bol'nykh gipertonicheskoi bolezn'iu.

As many as 56 healthy women and 45 women of reproductive age, suffering from essential hypertension (EH) were examined for the effect of ovarian cycle phases on vegetative regulation of central hemodynamics and pharmacodynamic effects of hemiton. The healthy persons in the phase of proliferation (I) and secretion (III) demonstrated the predominance of the parasympathetic tone and high responsiveness of the autonomic nervous system (ANS). The phase of ovulation (II) and the menstrual phase (IV) were characterized by the high sympathetic tone and low responsiveness of both parts of the ANS. The lowest values of the stroke and minute blood volumes were detected in phase II, whereas the highest ones in phase IV. In EH patients, the recurrence of ANS function was disturbed, the dynamics of the parameters became opposite to that seen in healthy persons. Hemiton produced the maximal hypotensive effect in phases I and II, the minimal one in phases III and IV. In phases I and III, the drug minimized the cardiac output; the general peripheral resistance was reduced in phases I and II; in phase IV, the drug did not provoke any significant changes in hemodynamics. The data obtained permit a differentiated approach to the distribution of the hemiton dose required for the treatment course in EH women of reproductive age.